手机版 客户端

PD-1/PD-L1通路介导姜黄素增效直肠肿瘤放射治疗的机制研究

PD-1/PD-L1通路介导姜黄素增效直肠肿瘤放射治疗的机制研究
  • 导航:首页 > 科学基金
  • 批准号:81602075
  • 批准年度: 2016年
  • 学科分类:消化系统肿瘤(H1617) |
  • 项目负责人:李燕燕
  • 负责人职称:医师
  • 依托单位:复旦大学
  • 资助金额:18万元
  • 项目类别:青年科学基金项目
  • 研究期限:2017年01月01日 至 2019年12月31日
  • 中文关键词: PD-1/PD-L1;姜黄素;增效;直肠肿瘤;放射治疗
  • 英文关键词:colorectal cancer;Radiation Synergistic Effect;Curcumin;PD-1/PD-L1 Pathway;Th17 cells

项目摘要

中文摘要

放射线抵抗普遍存在于多种肿瘤,影响放疗疗效。我们前期工作发现低剂量姜黄素可提高射线抵抗直肠肿瘤放疗效果,但机制不清。肿瘤微环境在放射抵抗中发挥重要作用,肿瘤组织中Th17细胞参与抗肿瘤免疫,我们进一步发现姜黄素联合放疗可下调肿瘤组织EBI3表达,且肿瘤微环境中EBI3缺失促进Th17细胞分化。PD-1/PD-L1信号通路调控T细胞分化及免疫应答,由EBI3亚基组成的IL-27可诱导肿瘤及淋巴细胞PD-L1、PD-1表达。因此提出假说:姜黄素联合放疗通过下调肿瘤微环境EBI3表达,负调控PD-1/PD-L1通路,促进Th17细胞分化,发挥抗肿瘤免疫。本课题将通过体内外实验明确姜黄素联合放疗对肿瘤微环境的调节,并探索该联合治疗促进Th17细胞分化的机制。本课题的实施将丰富我们对放射肿瘤微环境中Th17细胞功能的认识,并为姜黄素作为直肠癌放疗增效剂及Th17细胞治疗联合放疗提供坚实的理论依据。

英文摘要

Radiation resistance exists in almost all kinds of tumor and could reduce the effect of radiotherapy. We recently discovered low dose curcumin could improve the effect of radiotherapy for radiation resistant rectal cancer, but the underling mechanism is not clear. Tumor microenvironment plays an important role in radiation resistance, and the expression of Th17 cells in tumor tissue is associated with anti-tumor immunity. We further identified that curcumin combined with radiotherapy could down regulate EBI3 expression of tumor tissue and the EBI3 knock down mice showed improved Th17 cell differentiation in tumor tissue. PD-1/PD-L1 signal pathway is involved in T cell differentiation and the regulation of immunological responses. Besides, IL-27 cytokine composed by EBI3 subunit could induce the expression of PD-L1 in tumor cells and PD-1 in T cells. Thus, we put forward the hypothesis that curcumin combined with radiation therapy could down regulate EBI3 expression in tumor microenvironment, reverse the PD-1/PD-L1 pathway mediated Th17 cell differentiation inhibition, and enhance the anti-tumor immunity. Our study will first confirm the radiation synergistic effect of curcumin with the in vitro and in vivo experiments, underline the regulation of tumor microenvironment by the curcumin and radiation combination therapy, and then explore the mechanism for the promotion of Th17 cell differentiation. Our project will rich the role of Th17 cells in the tumor microenvironment, provide a solid theoretical basis for the clinical application of curcumin as radiation synergistic agent, and the application of Th17 cell therapy combined with radiotherapy for rectal cancer treatment.

评估说明

    国家自然科学基金项目“PD-1/PD-L1通路介导姜黄素增效直肠肿瘤放射治疗的机制研究”发布于爱科学iikx,并永久归类于相关科学基金导航中,仅供广大科研工作者查询、学习、选题参考。国科金是根据国家发展科学技术的方针、政策和规划,以及科学技术发展方向,面向全国资助基础研究和应用研究,发挥着促进我国基础研究源头创新的作用。国科金的真正价值在于它能否为科学进步和社会发展带来积极的影响。

此文由 爱科学 编辑!:首页 > 科学基金 > 科学基金3 » PD-1/PD-L1通路介导姜黄素增效直肠肿瘤放射治疗的机制研究

推荐文章